DNA and Synthetic Conjugate Vaccines

Conjugate antibodies, made up of a bacterial polysaccharide antigen cross-connected to a bacterial protein, are among the best immunizations accessible today to avert bacterial diseases, for example, pneumococcal and meningococcal contaminations. Conjugate antibodies against bacterial pathogens with a substantial number of serotypes, for example, Streptococcus pneumoniae, generally cover just a few the current strains. Another recombinant DNA-based assembling innovation has been created to avert genuine bacterial diseases. This innovation can possibly prompt antibodies against unmanageable pathogens, for example, S. aureus and Shigella species and to rearrange and enhance the proficiency of creating complex conjugate antibodies.

 

  • Adjuvant
  • DNA vaccination
  • Prime-boost Vaccination
  • Polysaccharide Chemistry and Glyco-Conjugate Vaccines
  • Reverse Vaccinology
  • DNA Immunization
  • DNA Plasmid
  • Pneumococcal Conjugate Vaccine

Related Conference of DNA and Synthetic Conjugate Vaccines

June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
July 29-30, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
November 12-13, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
November 21-22, 2019

World Conference on Vaccine and Immunology

Dubai, UAE
November 25-26 , 2019

Global meet on Immunology and Molecular Biology

Paris, France
November 28-29, 2019

International Conference on Vaccines and Immune Response

Helsinki, Finland

DNA and Synthetic Conjugate Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in